Stay updated on Etripamil Nasal Spray for SVT: Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray for SVT: Clinical Trial page.

Latest updates to the Etripamil Nasal Spray for SVT: Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions about the Open Label Extension study for Etripamil Nasal Spray in patients with Paroxysmal Supraventricular Tachycardia (PSVT) and the addition of a new revision number.SummaryDifference41%
Stay in the know with updates to Etripamil Nasal Spray for SVT: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray for SVT: Clinical Trial page.